Explore our news bulletins and archive
for the latest press coverage, as well as articles of interest.

Pay-for-delay ruling will bring more antitrust litigation

(Reuters) – When the U.S. Supreme Court issues its ruling on payments by brand-name drug companies to generic rivals to keep cheaper products off the market, many experts expect a complex analysis to emerge.